Skip to main content
AUTOBIO DIAGNOSTICS CO., LTD logo

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 ISIN · CNE100002GC4 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,291 across all filing types
Latest filing 2017-03-02 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

https://en.autobio.com.cn/

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
2016年度募集资金存放与使用情况专项审核报告
Regulatory Filings
2017-03-02 Chinese
关于公司控股股东及其他关联方资金占用情况的专项说明
Regulatory Filings
2017-03-02 Chinese
2016年度审计报告1
Regulatory Filings
2017-03-02 Chinese
媒体来访和投资者调研管理制度
Governance Information Classification · 95% confidence The document is titled '郑州安图生物工程股份有限公司 媒体来访和投资者调研管理制度' which translates to 'Zhengzhou Antu Bioengineering Co., Ltd. Media Visits and Investor Research Management System.' It outlines the company's internal policies and procedures for managing media visits and investor research activities, including principles of fairness, confidentiality, communication content, departmental responsibilities, and record-keeping. There is no financial data, no report or announcement of financial results, no voting results, no management changes, no legal proceedings, no capital changes, or any other regulatory filing content. The document is a governance-related internal policy document focused on investor relations and information disclosure management. Therefore, it fits best under Governance Information (CGR). The document length is 3357 characters, which is relatively short but contains substantive governance policy content, not just an announcement or a brief note. Hence, it is not RPA or RNS. Confidence is high due to clear governance content and absence of other filing characteristics.
2017-03-02 Chinese
2016年度独立董事述职报告
Board/Management Information Classification · 95% confidence The document is titled as the "2016年度独立董事述职报告" which translates to "2016 Annual Independent Directors' Report". It details the independent directors' work, attendance, opinions on company matters, and compliance with laws and regulations for the year 2016. It includes detailed descriptions of directors' backgrounds, attendance at board meetings, opinions on various company proposals, and evaluations of company governance and internal controls. The document is a report by the independent directors on their duties and activities for the year, which is a form of management or board report rather than a full annual report or audit report. It is not a financial statement or earnings release, nor is it an announcement or proxy material. This fits best under the category of Board/Management Information (MANG), as it relates to board members' activities and governance reporting by independent directors.
2017-03-02 Chinese
公司董事会审计委员会2016年度履职情况报告
Audit Report / Information Classification · 95% confidence The document is titled as a report on the 2016 annual performance of the company's Board Audit Committee. It details the committee's meetings, oversight of external auditors, internal control system supervision, and internal audit guidance. The content focuses on audit committee activities and their evaluation of audit and internal control processes for the year 2016. It is not a full annual report or standalone audit report but a specific committee report on audit oversight activities. This fits the category of Audit Report / Information (AR), which includes reports on audit committee activities and applied accounting principles, distinct from full annual reports or financial statements. The document length is 1645 characters, which is consistent with a committee report rather than a full annual report or earnings release. Therefore, the classification is AR with high confidence. FY 2016
2017-03-02 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.